Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies

Documenti analoghi

• The changing landscape of small cell lung cancer
  di: Giordano Fabricio Cittolin‐Santos, et al.
  Pubblicazione: (2024)
• Mapping the antibody–drug‐conjugates landscape in non–small cell lung cancer: Where are we and where are we going?
  di: Claudia Parisi, et al.
  Pubblicazione: (2026)
• A retrospective study of first‐line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations
  di: Li Wang, et al.
  Pubblicazione: (2024)
• The current therapeutic cancer vaccines landscape in non‐small cell lung cancer
  di: Shaoyi Chen, et al.
  Pubblicazione: (2024)
• Targeting HER2/HER3 co‐mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapy
  di: Page E. Blas, et al.
  Pubblicazione: (2024)